Mayfair Advisory Group, LLC Moderna, Inc. Transaction History

Mayfair Advisory Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$85.37 - $115.44 $10,415 - $14,083	122 Added 5.97%	2,164 $230,000
Q1 2023 Apr 20, 2023	BUY	$135.66 - $197.02 $6,783 - $9,851	50 Added 2.51%	2,042 $313,000
Q4 2022 Jan 27, 2023	BUY	$118.38 - $210.04 $35,514 - $63,012	300 Added 17.73%	1,992 $0
Q2 2022 Aug 09, 2022	BUY	$117.13 - $176.59 $198,183 - $298,790	1,692 New	1,692 $278,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Mayfair Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Mayfair Advisory Group, LLC with notifications on news.